Related Experiment Video

Updated: Aug 29, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

Vascular targeting agents

Mary Jo Pilat1, Julie McCormick, Patricia Mucci LoRusso

  • 1Karmanos Cancer Institute, 4100 John R, 4 HWCRC, Detroit, MI 48201, USA.

Current Oncology Reports
|January 31, 2004
PubMed

Insights

Vascular targeting agents (VTAs) offer new strategies to combat cancer by disrupting tumor blood vessels, leading to tumor cell death. These agents show promise alone or in combination therapies for improved antitumor effects.

Area of Science:

  • Oncology
  • Vascular Biology
  • Pharmacology

Background:

  • Tumor vascular networks are crucial for cancer growth and survival.
  • Early research focused on inhibiting new blood vessel formation (angiogenesis).
  • Current strategies aim to destroy existing tumor blood vessels.

Purpose of the Study:

  • To review the development and therapeutic potential of vascular targeting agents (VTAs).
  • To discuss the mechanisms of action for VTAs in cancer treatment.
  • To explore the efficacy of VTAs as monotherapy and in combination regimens.

Main Methods:

  • Review of current literature on vascular targeting agents.
  • Analysis of therapeutic strategies targeting tumor vasculature.
  • Examination of clinical trial data for VTAs.

Main Results:

  • Vascular targeting agents (VTAs) rapidly shut down tumor blood flow, causing ischemia and necrosis.
  • VTAs are broadly classified into biologic agents and small molecules.
  • Drug-based VTAs have advanced significantly, with numerous ongoing clinical trials.

Conclusions:

  • VTAs represent a promising therapeutic approach for cancer treatment.
  • Evidence suggests VTAs are effective as single agents and potentially more so in combination therapies.
  • Further research and clinical trials are warranted to optimize VTA utilization in cancer regimens.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...